Four in every 10 cancer patients treated with chemotherapy develop severe peripheral nerve pain, a new review suggests.

Have you experienced pain or tingling in your hands or feet? Those are signs of possible neuropathy, “a general term for ...

The Company anticipates completing enrollment of the 48-patient trial by the end of 2Q 2025 and releasing top-line data on the Phase 2a trial in 4Q 2025. Results from this trial are anticipated to be ...

Some health problems, including chronic pain, inflammation and neurological diseases, can be treated by nerve stimulation, ...

Chemotherapy has been known to cause damage to peripheral nerves, and sometimes the pain is chronic and severe enough that chemotherapy doses are reduced or discontinued. But prior research has not ...

Chronic pain is a global health challenge, with current treatment options often limited by side effects, addiction risk, and diminished effectiveness over time. In a new study, Yale researchers ...

Worldwide, cancer chemotherapy is linked to persistent severe peripheral nerve pain (neuropathy) for around 4 in every 10 patients treated with these drugs, suggests a pooled data analysis of the ...

Nalu Medical announces the FDA clearance for expanded labeling of its Peripheral Nerve Stimulation (PNS) System, now approved ...

Synchronizing vagus nerve stimulation with natural body rhythms, such as the heartbeat and breathing, significantly improves its effectiveness.

Nalu Medical announced today that the FDA cleared expanded labeling of its peripheral nerve system to include whole-body MRI ...

OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of neuropathic corneal pain (NCP), a severe ocular condition without an FDA approved therapy ...

Hospital length of stay, hospital costs, and opioid use were reduced among patients who underwent cryoablation during ...